Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)

NCT00382460 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT00382460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00382460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2000
Completion date
December 31, 2003
Enrollment
4,000
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

actue coronary syndromes